Plasma Levels of Arginine Vasopressin Elevated in Patients with Major Depression

被引:0
|
作者
Liesbeth van Londen
Jaap G Goekoop
Godfried MJ van Kempen
Ank C Frankhuijzen-Sierevogel
Victor M Wiegant
Edo A van der Velde
David De Wied
机构
[1] Leiden University,From the Department of Psychiatry
[2] Leiden University,Department of Medical Statistics
[3] Rudolf Magnus Institute for Neurosciences,Department of Medical Pharmacology
[4] Utrecht University,undefined
来源
Neuropsychopharmacology | 1997年 / 17卷
关键词
Arginine vasopressin; Oxytocin; Cortisol; Major depressive episode; Neuroticism; Psychomotor retardation;
D O I
暂无
中图分类号
学科分类号
摘要
Mentally healthy subjects show increased plasma concentrations of the neuropeptides, arginine vasopressin (AVP) and oxytocin (OT), under conditions of stress, but data are lacking about plasma concentrations of AVP and OT in patients with major depression. We thus assessed plasma concentrations of AVP and OT in patients with major depression (n = 52) and healthy controls (n = 37). Mean plasma AVP concentrations were higher in the group of depressed patients than in controls. A subgroup of 16 patients showed very high levels of plasma AVP, but no other feature differentiating this subgroup from the other patients was found. In-patients showed higher plasma AVP levels than out-patients, and melancholic patients had higher plasma AVP levels than did nonmelancholic patients. Plasma AVP levels were slightly related to psychomotor retardation and significantly inversely to neuroticism. Patients' plasma OT concentrations had a wider range than in controls. AVP and AVP-mediated functions may be a factor in the clinical picture of depression, possibly by influencing the activity of the hypothalamic-pituitary-adrenal axis. © 1997 American College of Neuropsyphopharmacology
引用
收藏
页码:284 / 292
页数:8
相关论文
共 50 条
  • [31] Influences of hydrocortisone therapy on arginine vasopressin plasma levels in septic shock
    Jochberger, Stefan
    Duenser, Martin W.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (7-8) : 245 - 247
  • [32] Arginine vasopressin increases plasma levels of von Willebrand factor in sheep
    S Rehberg
    R Laporte
    P Enkhbaatar
    E La
    K Wisniewski
    L Traber
    P Riviere
    DL Traber
    [J]. Critical Care, 13 (Suppl 1):
  • [33] Arginine vasopressin plasma levels could indicate childern undergoing cardiopulmonary bypass that might benefit from exogenous arginine vasopressin
    Ciomartan, Tatiana
    [J]. CRITICAL CARE MEDICINE, 2010, 38 (10) : 2079 - 2081
  • [34] VARIABILITY OF ARGININE VASOPRESSIN (AVP) LEVELS IN HOSPITALIZED PATIENTS WITH HYPONATREMIA
    Win, Sandar
    Mavani, Gaurang
    DeVita, Maria V.
    Michelis, Michael F.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (04) : A90 - A90
  • [35] ELEVATED ARGININE VASOPRESSIN LEVELS IN CONGESTIVE HEART-FAILURE AND RESPONSE TO NITROPRUSSIDE AND CAPTOPRIL
    GOLDSMITH, SR
    FRANCIS, GS
    LEVINE, TB
    COWLEY, A
    COHN, JN
    [J]. CLINICAL RESEARCH, 1981, 29 (02): : A495 - A495
  • [36] Increased plasma arginine vasopressin levels in dopamine agonist-treated Parkinson's disease patients
    Arai, Motomi
    [J]. NEUROENDOCRINOLOGY LETTERS, 2011, 32 (01) : 39 - 43
  • [37] Plasma copeptin levels before and during exogenous arginine vasopressin infusion in patients with advanced vasodilatory shock
    Torgersen, C.
    Luckner, G.
    Morgenthaler, N. G.
    Jochberger, S.
    Schmittinger, C. A.
    Wenzel, V.
    Hasibeder, W. R.
    Grander, W.
    Duenser, M. W.
    [J]. MINERVA ANESTESIOLOGICA, 2010, 76 (11) : 905 - 912
  • [38] Ghrelin Plasma Levels Are Not Altered in Major Depression
    Kluge, Michael
    Schuessler, Petra
    Schmid, Dagmar
    Uhr, Manfred
    Kleyer, Sara
    Yassouridis, Alexander
    Steiger, Axel
    [J]. NEUROPSYCHOBIOLOGY, 2009, 59 (04) : 199 - 204
  • [39] DECREASED PLASMA TRYPTOPHAN LEVELS IN MAJOR DEPRESSION
    COWEN, PJ
    PARRYBILLINGS, M
    NEWSHOLME, EA
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 1989, 16 (01) : 27 - 31
  • [40] Ghrelin plasma levels are not altered in major depression
    Kluge, M.
    Schuessler, P.
    Schmid, D.
    Uhr, M.
    Kleyer, S.
    Yassouridis, A.
    Steiger, A.
    [J]. PHARMACOPSYCHIATRY, 2009, 42 (05) : 226 - 227